MitoProteome Database

MT000961

UniProt Annotations

Entry Information
Gene NameAF4/FMR2 family, member 4
Protein EntryAFF4_HUMAN
UniProt IDQ9UHB7
SpeciesHuman
Comments
Comment typeDescription
Alternative Products Event=Alternative splicing; Named isoforms=3; Name=1; IsoId=Q9UHB7-1; Sequence=Displayed; Name=2; IsoId=Q9UHB7-2; Sequence=VSP_019220, VSP_019221; Name=3; IsoId=Q9UHB7-3; Sequence=VSP_019218, VSP_019219;
Developmental Stage Expressed in fetal heart, lung, brain and to a lower extent liver. {ECO:0000269|PubMed:10588740}.
Disease Note=A chromosomal aberration involving AFF4 is found in acute lymphoblastic leukemia (ALL). Insertion ins(5;11)(q31;q13q23) that forms a KMT2A/MLL1-AFF4 fusion protein.
Function Key component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. In the SEC complex, AFF4 acts as a central scaffold that recruits other factors through direct interactions with ELL proteins (ELL, ELL2 or ELL3) and the P-TEFb complex. In case of infection by HIV-1 virus, the SEC complex is recruited by the viral Tat protein to stimulate viral gene expression. {ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:23251033}.
Interaction O60563:CCNT1; NbExp=5; IntAct=EBI-395282, EBI-2479671; Q03111:MLLT1; NbExp=8; IntAct=EBI-395282, EBI-1384215; P42568:MLLT3; NbExp=4; IntAct=EBI-395282, EBI-716132; P04608:tat (xeno); NbExp=4; IntAct=EBI-395282, EBI-6164389;
Sequence Caution Sequence=AAI00288.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305}; Sequence=BAD92784.1; Type=Erroneous initiation; Evidence={ECO:0000305};
Similarity Belongs to the AF4 family. {ECO:0000305}.
Subcellular Location Nucleus {ECO:0000269|PubMed:12065898}. Note=Associates to transcriptionally active chromatin but not at snRNA genes. {ECO:0000250}.
Subunit Interacts with ELL3; the interaction is direct (By similarity). Interacts with ELL2; the interaction is direct and leads to stabilize ELL2 and prevent ELL2 ubiquitination and degradation. Component of the super elongation complex (SEC), at least composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the P-TEFb complex and ELL (ELL, ELL2 or ELL3). Interacts with ELL. {ECO:0000250, ECO:0000269|PubMed:12065898, ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:22483617}.
Tissue Specificity Ubiquitously expressed. Strongly expressed in heart, placenta, skeletal muscle, pancreas and to a lower extent in brain. {ECO:0000269|PubMed:10588740, ECO:0000269|PubMed:12065898}.
Web Resource Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/AF5q31ID230.html";